Table 8 Susceptibility* of all pathogens from Turkey: Combined pathogens and pathogen groups for doripenem, imipenem, and meropenem
From: Comparative activity of carbapenem testing (the COMPACT study) in Turkey
Turkey | N | Percentage of isolates | ||
|---|---|---|---|---|
Susceptible | Intermediate | Resistant | ||
All pathogens | 596 | |||
Doripenem | 69.5 | 11.1 | 19.5 | |
Imipenem | 68.1 | 3.4 | 28.5 | |
Meropenem | 69.8 | 9.7 | 20.5 | |
Pseudomonas spp. | 297 | |||
Doripenem | 56.6 | 17.5 | 25.9 | |
Imipenem | 53.9 | 4.0 | 42.1 | |
Meropenem | 56.2 | 15.8 | 28.0 | |
Enterobacteriaceae | 240 | |||
Doripenem | 97.9 | 0.8 | 1.3 | |
Imipenem | 97.9 | 0.8 | 1.3 | |
Meropenem | 98.3 | 0.4 | 1.3 | |
Other Gram negatives | 59 | |||
Doripenem | 18.6 | 20.3 | 61.0 | |
Imipenem | 18.6 | 10.2 | 71.2 | |
Meropenem | 22.0 | 17.0 | 61.0 | |